Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 334.75
-25.85 (-7.17%)
At close: Jan 20, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 37.14 billion as of January 23, 2026. Its market cap has increased by 1.20% in one year.
Market Cap
37.14B
Enterprise Value
37.75B
Revenue
1.55B
Ranking
n/a
PE Ratio
76.83
Stock Price
334.75
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 37.14B, an increase of 106,611.08%. That is a compound annual growth rate of 33.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 37.14B | -22.97% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 174.64B |
| Sudeep Pharma | 60.82B |
| Shilpa Medicare | 53.34B |
| Suven Life Sciences | 30.77B |
| IOL Chemicals and Pharmaceuticals | 21.01B |
| Bajaj HealthCare | 11.49B |
| NGL Fine-Chem | 9.30B |
| Anlon Healthcare | 6.75B |